Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
|
Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Atrial natriuretic peptide and leptin interactions in healthy men.
Front. Endocrin. 14:1195677 (2023)
INTRODUCTION: Atrial natriuretic peptide (ANP), a hormone secreted from the heart, controls cardiovascular and renal functions including arterial blood pressure and natriuresis. ANP also exerts metabolic effects in adipose tissue, liver and skeletal muscle, and interacts with the secretion of adipokines. We tested the hypothesis that ANP lowers concentrations of the anorexigenic adipokine leptin in healthy humans in vivo. METHODS: Human ANP or matching placebo was infused intravenously (iv) into healthy men in a controlled clinical trial. RESULTS: Within 135 minutes of iv ANP infusion, we observed an acute decrease in plasma leptin levels compared to controls. Free fatty acids markedly increased with ANP infusion in vivo, indicating activated lipolysis. In human SGBS adipocytes, ANP suppressed leptin release. DISCUSSION: The study shows that the cardiac hormone ANP reduces the levels of the anorexigenic adipokine leptin in healthy humans, providing further support for ANP as a cardiomyokine in a heart - adipose tissue axis. (registered in the German Clinical Trials Register and the WHO International Clinical Trials Registry Platform was granted under DRKS00024559).
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Anp ; Atrial Natriuretic Peptide ; Heart Failure ; Insulin Resistance ; Leptin ; Lipolysis ; Obesity; Secretion; Capacity
ISSN (print) / ISBN
1664-2392
e-ISSN
1664-2392
Zeitschrift
Frontiers in Endocrinology
Quellenangaben
Band: 14,
Artikelnummer: 1195677
Verlag
Frontiers
Verlagsort
Lausanne
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Diabetes Research and Metabolic Diseases (IDM)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes and Obesity (IDO)
Förderungen
Helmholtz Association by a Helmholtz Young Investigator Group
German Center for Diabetes Research (DZD)
German Research Foundation
Deutsche Forschungsgemeinschaft
German Center for Diabetes Research (DZD)
German Research Foundation
Deutsche Forschungsgemeinschaft